← Back to Search

Behavioral Intervention

LYNX for HIV/AIDS (COMPARE Trial)

N/A
Waitlist Available
Led By Katie B Biello, PhD, MPH
Research Sponsored by Public Health Foundation Enterprises, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post baseline
Awards & highlights

COMPARE Trial Summary

This study is evaluating whether two different apps may help young men who have sex with men learn about HIV and PrEP.

Eligible Conditions
  • HIV/AIDS
  • Pre-Exposure Prophylaxis
  • Risk Reduction
  • Sexually Transmitted Infections

COMPARE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Efficacy for HIV testing: Proportion who complete >= 1 HIV test
Efficacy for PrEP uptake: Proportion who uptake PrEP
Efficacy for STI testing: Proportion who complete >=1 STI test

COMPARE Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyChoicesExperimental Treatment1 Intervention
MyChoices is adapted from an app for adult MSM, HealthMindr, developed using SCT. The app aims to increase HIV testing and PrEP uptake by increasing self- regulation, self-reflection, and self-efficacy around HIV testing and PrEP uptake. Brief surveys about sexual risk and protective health behaviors within the app are used to assist users in tracking and self-monitoring their behaviors and creating a personalized HIV testing plan. Quizzes, videos and infographics as well as "Help me Choose," "Ordering," and geofencing functions are used to maximize self-efficacy around HIV prevention and uptake of PrEP.
Group II: LYNXExperimental Treatment1 Intervention
LYNX is developed using IMB model and engages youth through entering sexual diary data, earning badges, and calculating a personalized sexual protection (Sex Pro) score, which informs and motivates youth around HIV/STI testing and PrEP uptake. Behavioral skills are built through HIV/STI testing reminders, presenting options for home HIV testing and/or linkage to nearby testing services, and access to an online chat with support for HIV/STI testing and PrEP referral.
Group III: Standard of CareActive Control1 Intervention
Provision of referrals to local HIV/STI testing and PrEP resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyChoices
2019
N/A
~450
LYNX
2019
N/A
~390

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER
1,636 Previous Clinical Trials
2,560,192 Total Patients Enrolled
The Children's Hospital at Montefiore (CHAM)UNKNOWN
University of North Carolina, Chapel HillOTHER
1,504 Previous Clinical Trials
4,187,281 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Comparison of Men's Prevention Apps to Research Efficacy
Albert Liu 2019. "Comparison of Men's Prevention Apps to Research Efficacy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03965221.
~69 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top